3,7-Dibromo-5H-cyclopenta[1,2-b:5,4-b']dipyridin-5-one

Catalog No. :
ACEJZT107
CAS No. :
77213-41-3
Molecular Formula :
C11H4Br2N2O
Molecular Weight :
339.97

IUPAC Name:3,7-dibromo-5H-cyclopenta[2,1-b:3,4-b']dipyridin-5-one

3,7-Dibromo-5H-cyclopenta[1,2-b:5,4-b']dipyridin-5-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$76.00Login to see priceIn stockInquiry
250mg95%$99.00Login to see priceIn stockInquiry
1g95%$201.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,7-Dibromo-5H-cyclopenta[1,2-b:5,4-b']dipyridin-5-one
IUPAC Name3,7-dibromo-5H-cyclopenta[2,1-b:3,4-b']dipyridin-5-one
MDL No.-
Molecular FormulaC11H4Br2N2O
Molecular Weight339.97
SMILESO=C1C2=CC(Br)=CN=C2C3=NC=C(Br)C=C31
InChI KeyVJJFFJKBCKNOLZ-UHFFFAOYSA-N
Synonym3,7-dibromo-5H-cyclopenta-dipyridin-5-one;2,7-Dibromo-4,5-Diazafluoren-9-one;8-hydroxy-10H-1,10-phenanthrolin-3-one;5H-Cyclopenta[2,1-b:3,4-b']dipyridin-5-one, 3,7-dibromo-;3,7-Dibromo-5H-cyclopenta[2,1-b:3,4-b']dipyridin-5-one;3,7-Dibromo-5H-cyclopenta[1,2-b:5,4-b']dipyridin-5-one;3,7-Dibromo-5H-cyclopentadieno [1,2-b: 5,4-b '] dipyridine-5-ketone
CAS No.77213-41-3
PubChem CID12651902

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACEJZT107 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEJZT107 route product structure diagram
    ACEJZT10777213-41-3 In Stock
Inquiry

2. ACEJZT107 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEJZT107 route product structure diagram
    ACEJZT10777213-41-3 In Stock
Inquiry

Comments (0)